Maze Therapeutics, Inc. (MAZE) vs uniQure N.V. (QURE)
- Maze Therapeutics, Inc. MAZE 27.53 +0.18%
- uniQure N.V. QURE 21.72 −3.55%
Maze Therapeutics, Inc. and uniQure N.V. are both Biotechnology companies. Maze Therapeutics, Inc. and uniQure N.V. are of similar size ($1.6B and $1.5B). Maze Therapeutics, Inc. has the higher net margin (0.00% vs −1,350.7%) and the lower return on invested capital (−112.4% vs 0.00%). Across the 13 metrics below, Maze Therapeutics, Inc. leads on 11 and uniQure N.V. on 2.
Valuation
Profitability
| Metric | MAZE | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 92.49% | 65.16% |
| Operating margin | 0.00% | (1,071.53%) | 0.00% |
| Net margin | 0.00% | (1,350.73%) | 0.00% |
| Free cash flow margin | 0.00% | (864.67%) | 0.00% |
| Return on equity | (37.35%) | (157.61%) | (56.36%) |
| Return on assets | (31.99%) | (32.13%) | (48.04%) |
| Return on invested capital | (112.36%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack